Dr. Quiroga is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1145 Olentangy River Rd
Fl 3
Columbus, OH 43212Phone+1 614-293-5066Fax+1 614-293-9449
Summary
- Dionisia Quiroga, DO, PhD is a medical oncologist based in Columbus, OH, with a subspecialty in breast cancer. She completed her medical education at Michigan State University College of Osteopathic Medicine in 2016 and completed her residency in Internal Medicine at Ohio State University Hospital in 2019. Additionally, she holds a Ph.D. in Cell and Molecular Biology (2014) and a B.S. in Physiology (2007), both from Michigan State University. Her recent publications focus on advancements in breast cancer treatment, particularly in tumor immunology and immunotherapy. Her work has been published in reputable journals such as JAMA Oncology, JCI Insight, Scientific Reports, and NPJ Breast Cancer.
Education & Training
Ohio State University HospitalResidency, Internal Medicine, 2016 - 2019
Michigan State University College of Osteopathic MedicineClass of 2016
Michigan State UniversityPh.D, Cell and Molecular Biology, 2014
Michigan State UniversityB.S., Physiology, 2007
Certifications & Licensure
OH State License 2016 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- A comparison of myeloid-derived suppressor cell populations in patients with ulcerated vs non-ulcerated melanoma receiving immune checkpoint blockade.Colin D Angell, Steven H Sun, Gabriella Lapurga, Brooke Benner, Dionisia Quiroga
Melanoma Research. 2025-04-01 - The association between allostatic load and lymphedema in breast cancer survivors.Barnabas Obeng-Gyasi, Yevgeniya Gokun, Mohamed I Elsaid, J C Chen, Barbara L Andersen
Supportive Care in Cancer. 2025-03-21 - Inhibition of Bruton's tyrosine kinase with PD-1 blockade modulates T cell activation in solid tumors.Emily Schwarz, Brooke Benner, Robert Wesolowski, Dionisia Quiroga, Logan Good
JCI Insight. 2024-11-08
Press Mentions
American Doctors Detect Alarming Shift in Who’s Getting Cancer NationwideJanuary 17th, 2025- Atezolizumab plus Carboplatin Boosts Survival in Metastatic TNBCDecember 17th, 2023
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
